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An extremely rare association of multiple familial
trichoepitheliomas and hereditary multiple
osteochondromas
Multiple familial trichoepitheliomas (MFT) and hereditary multi-
ple osteochondromas (HMO) are both rare and autosomal dom-
inant disorders. Herein, we describe the first case with the two
genetic syndromes together.
A 35-year-old Caucasian woman, with personal history of mul-
tiple excisions of painful osteochondromas in childhood, was
observed due to a facial dermatosis that appeared 15 years
ago. She indicated that her mother and maternal grandmother
had multiple osteochondromas, while her paternal grandmother
used to have similar facial lesions. General physical examination
showed multiple palpable bone masses in the knees, arms, and
forearms; short stature; ulnar shortening of the forearm; and
ulnar deviation of the wrist (Bessel–Hagen deformity). Dermato-
logic physical examination revealed multiple, rounded, grouped,
firm, and skin-colored papules scattered through the nasolabial
sulcus, nose, and frontal region (Fig. 1a). No extrafacial lesions
were observed. Histopathologic examination of two facial lesions
demonstrated multiple nodular proliferations of uniform basaloid
cells with focal peripheral palisading, numerous central keratin-
filled cysts, and clefts between stromal elements or between
stroma and adjacent dermis (Fig. 1b). X-ray images of the shoul-
ders, elbows, wrists, and knees were consistent with multiple
osteochondromas (Fig. 2). The genetic test found a heterozy-
gous mutation in the exon 9 of cylindromatosis gene (CYLD)
[c.1112C>A(p.Ser371*)], allowing the clinical diagnosis of MFT
and a new heterozygous frameshift mutation never described
before in the exostosin-1 gene (EXT1), leading to a change in
leucine to cysteine at position 667 [c.2000del (p.Leu667Cys-
fs*6)], supporting the clinical diagnosis of HMO. Since childhood
she periodically visits the orthopedic department and has been
submitted to multiple surgical excisions of symptomatic osteo-
chondromas. Surgical excision and CO2 LASER has been per-
formed in a few cutaneous lesions. The patient and the
remaining family were referred to the genetic department.
Multiple familial trichoepithelioma (OMIM 601606) is charac-
terized by multiple skin-colored small papules and nodules usu-
ally confined to the nasolabial folds, nose, forehead, and upper
lip, with frequent confluence of the lesions.1 Zhang et al.2 identi-
fied for the first time mutations in the CYLD gene on chromo-
some 16q12-q13, responsible for MFT. The CYLD gene acts as
a tumor suppressor and is critical for various signalling path-
ways.3 Inactivation of this gene may contribute to oncogenesis
by enhancing the degradation of proteins that suppress cell pro-
liferation or promote apoptosis.3,4 Simultaneously, it is involved
in the feedback inhibition of RANK signalling pathway in the
bone cells.5 Loss of CYLD results in a hyperproduction of
osteoclasts, which is associated with severe bone loss or osteo-
porosis.5 The association with bone tumors is not clear.5
On the other hand, hereditary multiple osteochondromas
(OMIM 133700) are characterized by multiple benign cartilage-
capped tumors that grow outward from the metaphyses of long
bones.6 Osteochondromas usually continue to grow until pub-
erty, and clinical manifestations include short stature, bone
deformities, skeletal abnormalities, compression of adjacent tis-
sues, and impaired articular function.7 The two genes responsi-
ble for HMO, EXT1, and EXT2, are also tumor suppressors
located at 8q24.11 and 11p11.2, respectively.6 They encode
glycosyltransferases required for heparin sulphate (HS) biosyn-
thesis. Heterozygous loss-of-function mutations lead to dis-
turbed interactions and systemic HS deficiency.8 HS is involved
in the regulation signalling of endochondral ossification and,
thereby, relevant to the normal skeletal development.9 Addition-
ally, HS also plays a vital role in hair follicle morphogenesis.
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Figure 1 (a) Multiple skin-colored papules and nodules on the face; (b) histological examination of a facial lesion showed
multiple nodular proliferations of uniform basaloid cells with focal peripheral palisading and small keratin-filled cysts
compatible with trichoepithelioma (H&E, 940)
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The mutation in EXT gene can lead to a dysregulated hair folli-
cle morphogenesis and consequently to the development of
benign adnexal neoplasm as trichoepitheliomas.10
Here we reported for the first time a coexistence of multiple
trichoepitheliomas and multiple osteochondromas in a carrier of
two germline mutations in CYLD and EXT1 genes. The genetic
analysis allowed us to diagnose MFT and HMO, two well-known
hereditary syndromes never described before together in a sin-
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Figure 2 (a) Ulnar shortening of the forearm and ulnar deviation of the wrist (Bessel–Hagen deformity); (b) Shoulders,
elbows, and wrists x-ray images showed multiple osteochondromas
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